Unknown

Dataset Information

0

Pharmacological management of bipolar disorder: Japanese expert consensus.


ABSTRACT:

Objectives

The aim of this study was to develop a consensus guideline by certified experts of the Japanese Society of Clinical Neuropsychopharmacology on the psychopharmacological treatment for bipolar disorders I and II (BP-I and BP-II), in order to fill the gap in the literature and provide more concrete guidance for challenging and controversial real-world situations.

Methods

Experts were asked to assess treatment options regarding 19 clinical situations of bipolar disorder with a nine-point Likert scale (one = "disagree" and nine = "agree"). According to the responses from 119 experts, the options were categorized into the first-, second-, and third-line treatments.

Results

For the treatment of BP-I, lithium monotherapy was categorized as a first-line treatment for manic episodes (mean ± standard deviation score, 7.0 ± 2.2), depressive episodes (7.1 ± 2.0), and the maintenance phase (7.8 ± 1.8). Combination therapy of lithium and an atypical antipsychotic was endorsed for manic episodes (7.7 ± 1.7), depressive episodes with (7.1 ± 2.0) and without mixed features (6.9 ± 2.2), and the maintenance phase (6.9 ± 2.1). Similarly, in BP-II, lithium monotherapy was categorized as a first-line treatment for hypomanic episodes (7.3 ± 2.2), depressive episodes (7.0 ± 2.2), and the maintenance phase (7.3 ± 2.3), while combination therapy of lithium and an atypical antipsychotic was recommended for hypomanic episodes (6.9 ± 2.4).No antipsychotic monotherapy or antidepressant treatment was categorized as a first-line treatment for any type of episode.

Conclusions

These recommendations reflect the current evidence and represent the experts' consensus on using lithium for the treatment of bipolar disorder. Clinicians should consider the effectiveness and adverse effects of antipsychotic and antidepressant medications for the treatment of bipolar disorder.

SUBMITTER: Sakurai H 

PROVIDER: S-EPMC7818260 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objectives</h4>The aim of this study was to develop a consensus guideline by certified experts of the Japanese Society of Clinical Neuropsychopharmacology on the psychopharmacological treatment for bipolar disorders I and II (BP-I and BP-II), in order to fill the gap in the literature and provide more concrete guidance for challenging and controversial real-world situations.<h4>Methods</h4>Experts were asked to assess treatment options regarding 19 clinical situations of bipolar disorder wit  ...[more]

Similar Datasets

| S-EPMC7946533 | biostudies-literature
| S-EPMC8971510 | biostudies-literature
| S-EPMC8485984 | biostudies-literature
| S-EPMC10391579 | biostudies-literature
| S-EPMC7546882 | biostudies-literature
| S-EPMC11307856 | biostudies-literature
| S-EPMC8049072 | biostudies-literature
| S-EPMC7673642 | biostudies-literature
| S-EPMC6889624 | biostudies-literature
| S-EPMC6698334 | biostudies-literature